← Back to all trials
Recruiting
NCT07685873
Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease
Conditions: Parkinson Disease, Parkinson Disease Dementia, Parkinson's Disease and Parkinsonism
Sex: All
Ages: 18 Years – 90 Years
Healthy volunteers: Yes
Enrollment: 200
Sponsor: Tianjin Medical University
Location: The First Affiliated Hospital of University of Science and Technology of China Hefei Anhui
Summary
To evaluate the potential usefulness of 18F-FPyCO/SMBT-1 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various MAO-B-related disease patients.
Eligibility Criteria
Inclusion Criteria:
\- (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated PD (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled TSPO PET/CT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.
Exclusion Criteria:
* patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.
Source: ClinicalTrials.gov (NCT07685873). StuddyBuddy aggregates publicly available trial information.
